How NICE guidelines are transforming services for brain cancer patients
Over 4,000 people are diagnosed with new cases of brain or central nervous system (CNS) cancer every year in the UK.
Despite its fairly low profile, brain cancer is actually the third leading cause of cancer-related death among men aged 15-54 years, and the fourth leading cause of cancer-related death among women between 15 and 34.
Management of patients with brain cancer typically involves a combination of surgery, radiotherapy and chemotherapy.
But for many years, researchers have found that patients with brain cancer have been subjected to a fragmented and uncoordinated pathway of care from diagnosis through to treatment and follow-up. In some cases this has been because resources are directed into tackling the bigger name cancers like breast and lung instead.
This prompted NICE to publish guidance in 2006 aimed at improving outcomes for people with brain and other central nervous system tumours.

